Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India
Clinical trial NCT03548337 · COMPLETED
Trial details
- NCT number
- NCT03548337
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2019-12-20
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.